The University of Southampton
University of Southampton Institutional Repository

Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease

Round, J.A., Jacklin, P., Fraser, R.B., Hughes, R.G., Mugglestone, M.A. and Holt, R.I.G. (2011) Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease Diabetologia, 54, (2), pp. 256-263. (doi:10.1007/s00125-010-1881-y). (PMID:20809381).

Record type: Article


Aims/hypothesis: the cost-effectiveness of eight strategies for screening for gestational diabetes (including no screening) was estimated with respect to the level of individual patient risk.

Methods: cost–utility analysis using a decision analytic model populated with efficacy evidence pooled from recent randomised controlled trials, from the funding perspective of the National Health Service in England and Wales. Seven screening strategies using various combinations of screening and diagnostic tests were tested in addition to no screening. The primary outcome measure was the incremental cost per quality-adjusted life-year (QALY) over a lifetime.

Results: the strategy that has the greatest likelihood of being cost-effective is dependent on the risk of gestational diabetes mellitus for each individual woman. When gestational diabetes mellitus risk is <1% then the no screening/treatment strategy is cost-effective; where risk is between 1.0% and 4.2% fasting plasma glucose followed by OGTT is most likely to be cost-effective; and where risk is >4.2%, universal OGTT is most likely to be cost-effective. However, acceptability of the test alters the most cost-effective strategy.

Conclusions/interpretation: screening for gestational diabetes can be cost-effective. The best strategy is dependent on the underlying risk of each individual and the acceptability of the tests used. The current study suggests that if a woman’s individual risk of gestational diabetes could be accurately predicted, then healthcare resource allocation could be improved by providing an individualised screening strategy

Full text not available from this repository.

More information

Published date: February 2011
Keywords: cost effectiveness, gestational diabetes, screening, risk factors, cost–utility
Organisations: Dev Origins of Health & Disease


Local EPrints ID: 166041
ISSN: 0012-186X
PURE UUID: 2c56ffd8-d84c-4c4d-ab53-4d9076999fa1
ORCID for R.I.G. Holt: ORCID iD

Catalogue record

Date deposited: 21 Oct 2010 13:17
Last modified: 18 Jul 2017 12:26

Export record



Author: J.A. Round
Author: P. Jacklin
Author: R.B. Fraser
Author: R.G. Hughes
Author: M.A. Mugglestone
Author: R.I.G. Holt ORCID iD

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.